Historical snapshot from Q2 2024.View current holdings →
In Q2 2024, Driehaus Capital held 234 positions worth $7.2B. They initiated 44 new positions and exited 251. Their largest holding was CRNX ($273.8M). Portfolio value grew +5.3% versus the prior quarter.
Portfolio Value (13F)
$7.2B
Holdings
234
Top 10 Concentration
24.8%
QoQ Change
+5.3%
Turnover
8.8%
Sector Breakdown
Biotechnology93%(220)
Other Healthcare7%(14)
Q2 2024 Holdings (234)
| # | Ticker | Company | Change | Value | % of Portfolio | SI % Float ? |
|---|---|---|---|---|---|---|
| 1 | CRNX | Crinetics Pharmaceuticals Inc. | Increased | $273.8M | 3.81% | 7.3% |
| 2 | TMDXOther Healthcare | TransMedics Group, Inc. | Increased | $223.8M | 3.12% | 38.4% |
| 3 | CCJ | Cameco Corp. | Increased | $192.6M | 2.68% | — |
| 4 | IBN | Icici Bank Ltd. | Increased | $183.4M | 2.55% | 1.1% |
| 5 | XENE | Xenon Pharmaceuticals Inc. | Increased | $172.3M | 2.40% | 6.3% |
| 6 | CAMT | Camtek Ltd. | Decreased | $167.7M | 2.34% | 8.7% |
| 7 | FTAIN | FTAI Aviation Ltd. | Decreased | $160.8M | 2.24% | — |
| 8 | PCVX | Vaxcyte Inc. | Increased | $146.1M | 2.04% | 11.7% |
| 9 | NTRA | Natera Inc. | Increased | $132.2M | 1.84% | 4.5% |
| 10 | AXON | Axon Enterprise, Inc. | Decreased | $127.8M | 1.78% | 5.7% |
| 11 | CRDO | Credo Technology Group Holding Ltd. | Increased | $121.1M | 1.69% | 6.7% |
| 12 | BRBR | Bellring Brands, Inc. | Increased | $117.9M | 1.64% | 12.1% |
| 13 | ONTO | Onto Innovation Inc. | Increased | $117.6M | 1.64% | 7.7% |
| 14 | MOD | Modine Manufacturing CO | Increased | $110.4M | 1.54% | 6.0% |
| 15 | GPCR | Structure Therapeutics Inc. | Increased | $101.2M | 1.41% | 14.5% |
| 16 | ELF | e.l.f. Beauty, Inc. | Held | $100.0M | 1.39% | 8.2% |
| 17 | GKOSOther Healthcare | Glaukos Corporation | Increased | $95.1M | 1.32% | 7.9% |
| 18 | COHR | Coherent Corp. | Increased | $94.5M | 1.32% | 6.6% |
| 19 | MNDY | monday.com Ltd. | Decreased | $93.8M | 1.31% | 14.6% |
| 20 | BROS | Dutch Bros Inc. | Increased | $93.0M | 1.29% | 50.5% |
| 21 | APGE | Apogee Therapeutics Inc. | Increased | $83.3M | 1.16% | 7.3% |
| 22 | NTNX | Nutanix, Inc. | Increased | $81.6M | 1.14% | 6.0% |
| 23 | WT | WisdomTree, Inc. | $75.1M | 1.05% | 17.6% | |
| 24 | CVNA | Carvana CO. | Increased | $74.9M | 1.04% | 12.6% |
| 25 | SOJF | Southern CO | Decreased | $72.1M | 1.00% | — |
| 26 | FN | Fabrinet | Increased | $68.0M | 0.95% | 6.1% |
| 27 | CLS | Celestica Inc. | Increased | $66.8M | 0.93% | 3.5% |
| 28 | TRPCF | Trip.com Group Ltd. | Decreased | $66.8M | 0.93% | — |
| 29 | STRL | Sterling Infrastructure, Inc. | Increased | $63.1M | 0.88% | 4.4% |
| 30 | HCIIP | HCI Group, Inc. | Decreased | $61.6M | 0.86% | — |
| 31 | SFM | Sprouts Farmers Market, Inc. | Increased | $61.5M | 0.86% | 18.7% |
| 32 | KMPB | Kemper Corp. | Decreased | $60.2M | 0.84% | — |
| 33 | ENVX | Enovix Corp. | Increased | $60.1M | 0.84% | 27.1% |
| 34 | DUOL | Duolingo, Inc. | Increased | $59.9M | 0.83% | 20.4% |
| 35 | AMKR | Amkor Technology, Inc. | New | $58.4M | 0.81% | 17.3% |
| 36 | DRS | Leonardo DRS, Inc. | Increased | $58.2M | 0.81% | 1.2% |
| 37 | BAP | Credicorp Ltd. | Increased | $57.9M | 0.81% | 2.3% |
| 38 | ESTC | Elastic N.V. | Increased | $56.9M | 0.79% | 5.2% |
| 39 | VSOGF | Vista Energy, S.A.B. de C.V. | Decreased | $56.1M | 0.78% | — |
| 40 | CR | Crane Co | Increased | $55.8M | 0.78% | 2.5% |
| 41 | UEC | Uranium Energy Corp. | Increased | $55.0M | 0.77% | 14.8% |
| 42 | TDGMW | Tidewater Inc. | Decreased | $53.0M | 0.74% | — |
| 43 | NUVL | Nuvalent Inc. | Increased | $52.8M | 0.74% | 6.2% |
| 44 | MELI | Mercadolibre Inc. | Increased | $52.0M | 0.72% | 1.8% |
| 45 | KNF | Knife River Corp. | Decreased | $49.0M | 0.68% | 10.2% |
| 46 | SAIA | Saia Inc. | Decreased | $48.8M | 0.68% | 4.5% |
| 47 | RYTM | Rhythm Pharmaceuticals Inc. | Increased | $48.5M | 0.68% | 15.8% |
| 48 | SPXC | SPX Technologies, Inc. | Increased | $47.8M | 0.67% | 4.2% |
| 49 | WFRD | Weatherford International plc | Decreased | $46.9M | 0.65% | 6.6% |
| 50 | FIX | Comfort Systems Usa Inc. | Increased | $46.4M | 0.65% | 2.8% |
| 51 | SKWD | Skyward Specialty Insurance Group, Inc. | Increased | $45.5M | 0.63% | 4.8% |
| 52 | SMTC | Semtech Corp. | New | $43.4M | 0.60% | 7.8% |
| 53 | FTI | TechnipFMC plc | Decreased | $42.7M | 0.59% | 3.5% |
| 54 | RXSTOther Healthcare | RxSight Inc. | Increased | $42.5M | 0.59% | 10.4% |
| 55 | EVER | EverQuote, Inc. | Increased | $42.5M | 0.59% | 29.6% |
| 56 | TER | Teradyne, Inc. | New | $41.5M | 0.58% | 6.4% |
| 57 | ITGR | Integer Holdings Corp. | Increased | $40.9M | 0.57% | 11.0% |
| 58 | BPMC | Blueprint Medicines Corporation | Increased | $38.6M | 0.54% | — |
| 59 | TNDMOther Healthcare | Tandem Diabetes Care Inc. | Decreased | $38.5M | 0.54% | 25.7% |
| 60 | PAASF | Pan American Silver Corp. | New | $38.1M | 0.53% | — |
| 61 | EVR | Evercore Inc. | Decreased | $37.8M | 0.53% | 3.2% |
| 62 | EMBJ | Embraer S.A. | Increased | $37.1M | 0.52% | 1.1% |
| 63 | DECK | Deckers Outdoor Corp. | Decreased | $34.9M | 0.49% | 9.7% |
| 64 | ADMA | ADMA Biologics Inc. | Increased | $33.9M | 0.47% | 11.3% |
| 65 | ARLO | Arlo Technologies, Inc. | Decreased | $33.8M | 0.47% | 13.7% |
| 66 | AAON | Aaon, Inc. | Increased | $33.6M | 0.47% | 8.2% |
| 67 | ESI | Element Solutions Inc. | New | $32.4M | 0.45% | 4.3% |
| 68 | VITL | Vital Farms, Inc. | Decreased | $31.9M | 0.44% | 29.1% |
| 69 | ROAD | Construction Partners, Inc. | Increased | $31.4M | 0.44% | 6.7% |
| 70 | ALKT | Alkami Technology, Inc. | Increased | $31.1M | 0.43% | 8.9% |
| 71 | LIVNOther Healthcare | LivaNova PLC | Increased | $29.8M | 0.42% | 12.5% |
| 72 | PSN | Parsons Corp. | New | $29.3M | 0.41% | 14.8% |
| 73 | ATI | Ati Inc. | Increased | $28.9M | 0.40% | 5.3% |
| 74 | OSW | Onespaworld Holdings Ltd. | Increased | $28.7M | 0.40% | 7.0% |
| 75 | LRN | Stride, Inc. | Decreased | $28.7M | 0.40% | 27.5% |
| 76 | GTLS | Chart Industries Inc. | Increased | $28.5M | 0.40% | 10.9% |
| 77 | AMD | Advanced Micro Devices Inc. | Decreased | $27.9M | 0.39% | 2.4% |
| 78 | GPOR | Gulfport Energy Corp. | Increased | $27.7M | 0.39% | 9.3% |
| 79 | APLD | Applied Digital Corp. | Decreased | $27.1M | 0.38% | 20.5% |
| 80 | BLBD | Blue Bird Corp. | Decreased | $27.1M | 0.38% | 16.6% |
| 81 | NRIX | Nurix Therapeutics Inc. | New | $26.8M | 0.37% | 16.3% |
| 82 | TBBB | Bbb Foods Inc. | New | $26.6M | 0.37% | 4.4% |
| 83 | PWR | Quanta Services, Inc. | Increased | $26.1M | 0.36% | 2.4% |
| 84 | DPZ | Dominos Pizza Inc. | Held | $25.8M | 0.36% | 9.0% |
| 85 | QNST | Quinstreet, Inc. | Increased | $25.1M | 0.35% | 13.6% |
| 86 | ADI | Analog Devices Inc. | New | $25.0M | 0.35% | 2.3% |
| 87 | AVAV | AeroVironment Inc. | Increased | $24.9M | 0.35% | 12.8% |
| 88 | PLMR | Palomar Holdings, Inc. | Increased | $24.4M | 0.34% | 3.4% |
| 89 | AGYS | Agilysys Inc. | Increased | $22.7M | 0.32% | 7.4% |
| 90 | VRTX | Vertex Pharmaceuticals Inc. | Increased | $22.7M | 0.32% | 2.0% |
| 91 | EWTX | Edgewise Therapeutics, Inc. | Held | $22.7M | 0.32% | 14.6% |
| 92 | ANET | Arista Networks, Inc. | Decreased | $22.5M | 0.31% | 1.1% |
| 93 | CUBB | Customers Bancorp, Inc. | Decreased | $22.5M | 0.31% | — |
| 94 | VRT | Vertiv Holdings Co | Decreased | $22.5M | 0.31% | 3.7% |
| 95 | AXP | American Express CO | Decreased | $22.0M | 0.31% | 2.1% |
| 96 | CELH | Celsius Holdings, Inc. | Decreased | $21.9M | 0.31% | 12.4% |
| 97 | MRCY | Mercury Systems Inc. | Decreased | $21.9M | 0.30% | 9.5% |
| 98 | KRYS | Krystal Biotech Inc. | Increased | $21.8M | 0.30% | 19.2% |
| 99 | LMATOther Healthcare | Lemaitre Vascular Inc. | Increased | $21.7M | 0.30% | 9.6% |
| 100 | RARE | Ultragenyx Pharmaceutical Inc. | Increased | $21.7M | 0.30% | 21.4% |
| 101 | PRCTOther Healthcare | PROCEPT BioRobotics Corp. | Increased | $21.3M | 0.30% | 13.3% |
| 102 | RXO | Rxo, Inc. | New | $20.0M | 0.28% | 25.0% |
| 103 | XYL | Xylem Inc. | Held | $19.6M | 0.27% | 5.8% |
| 104 | PTGX | Protagonist Therapeutics Inc. | Held | $19.3M | 0.27% | 16.8% |
| 105 | NXE | NexGen Energy Ltd. | Decreased | $19.3M | 0.27% | — |
| 106 | TWST | Twist Bioscience Corporation | Increased | $19.2M | 0.27% | 20.1% |
| 107 | LOPE | Grand Canyon Education, Inc. | Increased | $19.1M | 0.27% | 9.0% |
| 108 | GGAL | Grupo Financiero Galicia SA | Decreased | $19.1M | 0.27% | 18.9% |
| 109 | MAX | MediaAlpha, Inc. | Increased | $18.9M | 0.26% | 9.4% |
| 110 | CNTA | Centessa Pharmaceuticals plc | Increased | $18.9M | 0.26% | 1.2% |
| 111 | ITRI | Itron, Inc. | New | $18.8M | 0.26% | 19.4% |
| 112 | OSCR | Oscar Health, Inc. | Increased | $18.7M | 0.26% | 6.5% |
| 113 | CNNE | Cannae Holdings, Inc. | New | $18.6M | 0.26% | 10.3% |
| 114 | MNMD | Mind Medicine Inc. | Held | $18.3M | 0.25% | — |
| 115 | GDEN | Golden Entertainment, Inc. | Decreased | $18.0M | 0.25% | 4.0% |
| 116 | HOOD | Robinhood Markets, Inc. | New | $17.7M | 0.25% | 5.1% |
| 117 | AR | Antero Resources Corp. | New | $17.3M | 0.24% | 4.5% |
| 118 | AVPT | AvePoint, Inc. | New | $17.3M | 0.24% | 7.0% |
| 119 | CECO | Ceco Environmental Corp. | Increased | $16.9M | 0.24% | 3.7% |
| 120 | SITM | Sitime Corp. | Increased | $16.8M | 0.23% | 7.5% |
| 121 | FICO | Fair Isaac Corp. | Decreased | $16.6M | 0.23% | 12.5% |
| 122 | SYRE | Spyre Therapeutics, Inc. | $16.2M | 0.23% | 15.4% | |
| 123 | ATXS | Astria Therapeutics Inc. | Held | $15.9M | 0.22% | — |
| 124 | FORM | Formfactor Inc. | New | $15.9M | 0.22% | 5.9% |
| 125 | BLFY | Blue Foundry Bancorp | $15.6M | 0.22% | 3.8% | |
| 126 | RGLD | Royal Gold Inc. | Increased | $15.6M | 0.22% | 3.0% |
| 127 | IDYA | IDEAYA Biosciences Inc. | Decreased | $15.3M | 0.21% | 11.1% |
| 128 | WSC | WillScot Holdings Corp. | $15.1M | 0.21% | 12.2% | |
| 129 | FHN-PH | First Horizon Corp. | Decreased | $14.9M | 0.21% | — |
| 130 | ITCI | Intra-Cellular Therapies Inc. | New | $14.8M | 0.21% | — |
| 131 | HBM | Hudbay Minerals Inc. | New | $14.7M | 0.21% | — |
| 132 | WIX | Wix.com Ltd. | New | $13.6M | 0.19% | 18.8% |
| 133 | BV | BrightView Holdings, Inc. | New | $13.1M | 0.18% | 33.9% |
| 134 | WRBY | Warby Parker Inc. | Increased | $13.0M | 0.18% | 20.9% |
| 135 | ICLROther Healthcare | Icon Plc | Increased | $12.5M | 0.17% | 4.1% |
| 136 | ARGX | argenx SE | Increased | $12.2M | 0.17% | 2.2% |
| 137 | POWL | Powell Industries Inc. | New | $11.7M | 0.16% | 11.1% |
| 138 | KNSA | Kiniksa Pharmaceuticals International, plc | Decreased | $11.5M | 0.16% | 9.4% |
| 139 | WGSWWOther Healthcare | GeneDx Holdings Corp. | New | $11.3M | 0.16% | — |
| 140 | MEDPOther Healthcare | Medpace Holdings Inc. | Increased | $11.3M | 0.16% | 7.1% |
| 141 | LII | Lennox International Inc. | New | $11.1M | 0.15% | 9.8% |
| 142 | ASND | Ascendis Pharma A/S | Decreased | $11.1M | 0.15% | 6.3% |
| 143 | PRAX | Praxis Precision Medicines, Inc. | Held | $10.9M | 0.15% | 15.0% |
| 144 | RSI | Rush Street Interactive, Inc. | New | $10.6M | 0.15% | 9.0% |
| 145 | GLNG | Golar Lng Ltd. | New | $10.6M | 0.15% | 11.8% |
| 146 | HLI | Houlihan Lokey, Inc. | Decreased | $10.3M | 0.14% | 4.4% |
| 147 | BAH | Booz Allen Hamilton Holding Corp. | New | $10.3M | 0.14% | 6.5% |
| 148 | HLMN | Hillman Solutions Corp. | $10.2M | 0.14% | 2.8% | |
| 149 | HWM | Howmet Aerospace Inc. | Decreased | $10.2M | 0.14% | 2.6% |
| 150 | WULF | Terawulf Inc. | New | $9.9M | 0.14% | 28.1% |
| 151 | MGNI | Magnite, Inc. | Increased | $9.9M | 0.14% | 8.6% |
| 152 | TARS | Tarsus Pharmaceuticals Inc. | Increased | $9.9M | 0.14% | 13.4% |
| 153 | NBIX | Neurocrine Biosciences Inc. | Held | $9.8M | 0.14% | 7.5% |
| 154 | DAWN | Day One Biopharmaceuticals Inc. | Decreased | $9.7M | 0.14% | 7.5% |
| 155 | GBX | Greenbrier Companies Inc. | Decreased | $9.7M | 0.13% | 12.7% |
| 156 | LRMR | Larimar Therapeutics, Inc. | Increased | $9.5M | 0.13% | 22.9% |
| 157 | VERA | Vera Therapeutics Inc. | Held | $9.2M | 0.13% | 27.2% |
| 158 | BWMN | Bowman Consulting Group Ltd. | Decreased | $8.8M | 0.12% | 4.8% |
| 159 | FANG | Diamondback Energy, Inc. | Decreased | $8.5M | 0.12% | 3.8% |
| 160 | BHVN | Biohaven Pharmaceutical Holding | Decreased | $8.5M | 0.12% | 16.1% |
| 161 | ALNY | Alnylam Pharmaceuticals Inc. | Increased | $7.9M | 0.11% | 7.7% |
| 162 | TERN | Terns Pharmaceuticals Inc. | $7.4M | 0.10% | 7.0% | |
| 163 | INSM | Insmed Incorporated | New | $7.0M | 0.10% | 7.1% |
| 164 | LIN | Linde Plc | Decreased | $6.8M | 0.10% | 1.3% |
| 165 | INCY | Incyte Corporation | Decreased | $6.8M | 0.09% | 8.4% |
| 166 | GWRE | Guidewire Software, Inc. | New | $6.7M | 0.09% | 4.0% |
| 167 | KYMR | Kymera Therapeutics Inc. | New | $6.7M | 0.09% | 15.3% |
| 168 | KALV | KalVista Pharmaceuticals, Inc. | Decreased | $6.3M | 0.09% | 14.4% |
| 169 | SLNO | Soleno Therapeutics Inc. | New | $5.9M | 0.08% | 17.9% |
| 170 | GXO | GXO Logistics, Inc. | $5.8M | 0.08% | 7.3% | |
| 171 | HYAC-WT | Haymaker Acquisition Corp. 4 | $5.3M | 0.07% | — | |
| 172 | SKYE | Skye Bioscience, Inc. | New | $5.2M | 0.07% | 4.7% |
| 173 | PACK | Ranpak Holdings Corp. | Increased | $5.2M | 0.07% | 5.3% |
| 174 | CLYM | Climb Bio, Inc. | Decreased | $4.9M | 0.07% | 23.9% |
| 175 | ATECOther Healthcare | Alphatec Holdings, Inc. | Decreased | $4.8M | 0.07% | 10.5% |
| 176 | AAPL | Apple Inc. | Increased | $4.7M | 0.07% | 0.8% |
| 177 | MSFT | Microsoft Corp. | Held | $4.6M | 0.06% | 0.8% |
| 178 | VTOL | Bristow Group Inc. | New | $4.6M | 0.06% | 5.1% |
| 179 | WVE | Wave Life Sciences Ltd. | Increased | $4.5M | 0.06% | 11.6% |
| 180 | GAUZ | Gauzy Ltd. | New | $4.3M | 0.06% | 0.8% |
| 181 | NVDA | Nvidia Corp. | Increased | $4.1M | 0.06% | 1.3% |
| 182 | RLAY | Relay Therapeutics Inc. | Increased | $4.0M | 0.06% | 24.8% |
| 183 | KRRO | Korro Bio, Inc. | New | $4.0M | 0.06% | 12.7% |
| 184 | NGNE | Neurogene Inc. | Increased | $3.7M | 0.05% | 29.5% |
| 185 | CGON | CG Oncology, Inc. | Held | $3.4M | 0.05% | 12.0% |
| 186 | CELC | Celcuity Inc. | Increased | $3.4M | 0.05% | 33.7% |
| 187 | FHTX | Foghorn Therapeutics Inc. | Increased | $3.3M | 0.05% | 6.6% |
| 188 | MLYS | Mineralys Therapeutics, Inc. | Increased | $3.0M | 0.04% | 10.6% |
| 189 | GOOG | Alphabet Inc. | Increased | $3.0M | 0.04% | — |
| 190 | SWTX | SpringWorks Therapeutics Inc. | Decreased | $2.9M | 0.04% | — |
| 191 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | $2.9M | 0.04% | 18.1% | |
| 192 | CDNA | CareDx Inc. | New | $2.9M | 0.04% | 13.0% |
| 193 | BRCB | Black Rock Coffee Bar, Inc. | $2.8M | 0.04% | 9.7% | |
| 194 | LOAR | Loar Holdings Inc. | New | $2.4M | 0.03% | 16.0% |
| 195 | AUTL | Autolus Therapeutics plc | Decreased | $2.3M | 0.03% | 4.9% |
| 196 | MMYT | MakeMyTrip Ltd. | Increased | $2.2M | 0.03% | 14.2% |
| 197 | XOM | Exxon Mobil Corp. | Decreased | $1.9M | 0.03% | 1.1% |
| 198 | VINP | Vinci Compass Investments Ltd. | Increased | $1.7M | 0.02% | 1.0% |
| 199 | LLY | Eli Lilly & Co | Increased | $1.5M | 0.02% | 0.8% |
| 200 | AVGO | Broadcom Inc. | Decreased | $1.3M | 0.02% | 1.2% |
| 201 | TTD | Trade Desk, Inc. | New | $1.2M | 0.02% | 23.0% |
| 202 | CTNM | Contineum Therapeutics, Inc. | New | $1.2M | 0.02% | 9.4% |
| 203 | BEIGF | BeOne Medicines Ltd. | Increased | $1.2M | 0.02% | — |
| 204 | MSI | Motorola Solutions, Inc. | Increased | $1.2M | 0.02% | 2.3% |
| 205 | SPOT | Spotify Technology S.A. | Decreased | $1.1M | 0.02% | 2.7% |
| 206 | OVID | Ovid Therapeutics Inc. | Increased | $1.1M | 0.02% | 11.1% |
| 207 | LAUR | Laureate Education, Inc. | Increased | $1.1M | 0.01% | 3.9% |
| 208 | BEKE | KE Holdings Inc. | Increased | $1.1M | 0.01% | 4.8% |
| 209 | AZN | Astrazeneca Plc | Increased | $1.0M | 0.01% | 0.2% |
| 210 | ORIC | ORIC Pharmaceuticals Inc. | $1.0M | 0.01% | 15.9% | |
| 211 | UBER | Uber Technologies, Inc. | Decreased | $1.0M | 0.01% | 2.5% |
| 212 | CPA | Copa Holdings, S.A. | Decreased | $982K | 0.01% | 5.2% |
| 213 | TMOOther Healthcare | Thermo Fisher Scientific Inc. | Increased | $843K | 0.01% | 1.5% |
| 214 | GLD | Spdr Gold Trust | Decreased | $739K | 0.01% | — |
| 215 | ROP | Roper Technologies Inc. | Decreased | $706K | 0.01% | 5.3% |
| 216 | NOW | ServiceNow, Inc. | Decreased | $683K | 0.01% | 2.9% |
| 217 | SU | Suncor Energy Inc. | Increased | $675K | 0.01% | — |
| 218 | UTHR | United Therapeutics Corporation | Increased | $670K | 0.01% | 9.8% |
| 219 | SNPS | Synopsys Inc. | Decreased | $571K | 0.01% | 2.6% |
| 220 | GTLB | Gitlab Inc. | Decreased | $544K | 0.01% | 8.3% |
| 221 | NET | Cloudflare, Inc. | New | $522K | 0.01% | 2.7% |
| 222 | CCXIW | Churchill Capital Corp XI | Increased | $506K | 0.01% | — |
| 223 | TFC-PR | Truist Financial Corp. | Decreased | $478K | 0.01% | — |
| 224 | SHOP | Shopify Inc. | Decreased | $471K | 0.01% | 1.7% |
| 225 | DELL | Dell Technologies Inc. | New | $437K | 0.01% | 4.2% |
| 226 | LABOther Healthcare | Standard Biotools Inc. | $419K | 0.01% | 1.1% | |
| 227 | SYKOther Healthcare | Stryker Corp. | Increased | $377K | 0.01% | 1.6% |
| 228 | GLPGF | Galapagos NV | $278K | 0.00% | — | |
| 229 | ETN | Eaton Corp plc | Decreased | $278K | 0.00% | 2.1% |
| 230 | VZ | Verizon Communications Inc. | Decreased | $251K | 0.00% | 2.1% |
| 231 | RJF | Raymond James Financial Inc. | New | $244K | 0.00% | 3.9% |
| 232 | FISV | Fiserv Inc. | New | $237K | 0.00% | — |
| 233 | KLAC | Kla Corp. | Increased | $218K | 0.00% | 2.1% |
| 234 | CLDWW | Calidi Biotherapeutics, Inc. | New | $19K | 0.00% | — |
Top Movers This Quarter
Share changes reflect active decisions. Value changes include price moves.
Frequently asked questions
What stocks did Driehaus Capital own in Q2 2024?
Driehaus Capital held 234 biotech stocks in their 13F portfolio in Q2 2024. Their top positions include CRNX, TMDX, CCJ, IBN, XENE. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Driehaus Capital's portfolio worth in Q2 2024?
Driehaus Capital's tracked biotech portfolio was worth $7.2B across 234 positions, with total assets under management of approximately $28B. Portfolio values are based on 13F filings with the SEC.
What did Driehaus Capital buy in Q2 2024?
Driehaus Capital initiated 44 new positions in Q2 2024, including AMKR, SMTC, TER, PAASF, ESI and 39 more. They also increased 101 existing positions.
What did Driehaus Capital sell in Q2 2024?
Driehaus Capital fully exited 251 positions in Q2 2024, including TTEK, MNESP, ITUB, XPEL, WING and 246 more. They also trimmed 76 existing positions.
Is Driehaus Capital a biotech fund?
Growth-oriented investment firm founded by Richard Driehaus (d. 2021), now led by CEO Steve Weber. Michael Caldwell manages the healthcare/life sciences portfolio, applying growth-at-a-reasonable-price philosophy to biotech with a focus on companies with accelerating revenue growth and approaching commercial inflection points.
Want AI analysis, insider signals, and catalyst overlays for Driehaus Capital?
View latest Driehaus Capital portfolio →